Proteomic Detection of Chronic Sinusitis Pathogens
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for bacterial infections in the upper respiratory tract, such as sinusitis, are inadequate due to the inability to distinguish between commensal and pathogenic bacteria, leading to inappropriate antibiotic use and antibiotic resistance, as traditional microbiological culture techniques have low sensitivity and specificity, especially for biofilms and nasopharyngeal flora.
Innovation Solution
A proteomic approach that identifies specific bacterial protein profiles, particularly using outer membrane proteins like OMP P5 and OMP P2, to differentiate between commensal and pathogenic bacteria by detecting signature proteins in biofilm supernatants from the paranasal sinus cavities, enabling early and rapid identification of pathogens like NTHI, Haemophilus influenzae, and other bacteria causing chronic sinusitis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional microbiological culture techniques are used, then diagnostic methods are simple and widely available, but they have low sensitivity and specificity for distinguishing commensal and pathogenic bacteria
Solution Approach 1:
The patent extracts and detects specific bacterial proteins (outer membrane proteins P2 and P5) from complex biological samples using immunoassays. This extraction of key diagnostic markers from the overall bacterial culture enables specific identification of pathogenic bacteria without requiring full cultural analysis, thereby improving diagnostic accuracy while managing complexity.
Solution Approach 2:
The patent uses antibodies as intermediary molecules to detect specific bacterial proteins. These antibodies serve as mediators that bind selectively to pathogenic bacterial markers, enabling indirect but highly specific detection of pathogens without direct observation or culture, thus resolving the contradiction between simplicity and accuracy.
2Reliability
If traditional culture methods are used, then the diagnostic process is straightforward, but it fails to detect microorganisms growing within biofilms and leads to contamination by resident colonizing flora
Solution Approach 1:
The patent extracts specific protein markers from biofilm environments and contaminated samples, allowing detection of pathogens even when they are embedded in biofilms or mixed with commensal flora. This extraction approach bypasses the limitations of traditional culture methods that cannot penetrate biofilms or distinguish pathogens from contaminants.
Solution Approach 2:
The patent applies local quality by targeting specific proteins (outer membrane proteins P2 and P5) that are locally present in pathogenic bacteria but absent or different in commensal organisms. This localized protein detection provides high reliability for pathogen identification without being affected by the presence of other bacteria in the sample.
3Reliability
If antibiotic use is increased to treat suspected bacterial infections, then treatment coverage is improved, but antibiotic resistance emerges and commensal flora is modified
Solution Approach 1:
The patent implements feedback by using detected protein levels to guide antibiotic prescribing decisions. The immunoassay provides quantitative information about pathogen presence and load, allowing clinicians to adjust treatment intensity accordingly - treating only when pathogens are detected above threshold levels, thereby maintaining treatment effectiveness while reducing unnecessary antibiotic exposure that drives resistance.
Data Source
AI summary
The invention provides for a proteomic approach for identification of specific bacterial protein profiles that may be used in the development of methods for the diagnosis of bacterial chronic sinusitis. The invention provides for methods for determining the presence of pathogenic bacteria in the upper respiratory tract of a subject using protein profiles of the pathogenic bacteria. The invention also provides for methods of diagnosing a bacterial infection of the upper respiratory tract of a subject using protein profiles of a pathogenic bacteria. In addition, the invention provides for devices, immunoassays and kits for identifying pathogenic bacteria in the upper respiratory tract.